top of page

Organs involved

Brain areas affected

Functions affected

Processes affected

Social issues 

Prone countries 

Denmark, Sweden, Germany, Ireland, Singapore, Australia, Netherlands, Belgium, Finland, Liechtenstein, United Kingdom, New Zealand, United Arab Emirates, Canada, Korea (Republic of), Luxembourg, United States, Austria, Slovenia, Japan, Israel, Malta, Spain, France, Cyprus, Italy, Estonia, Czechia, Greece, Bahrain, Andorra, Poland, Latvia, Lithuania, Croatia, Qatar, Saudi Arabia, Portugal, San Marino, Chile, Slovakia, Türkiye, Hungary, Argentina, Kuwait, Montenegro, Saint Kitts and Nevis, Uruguay, Romania, Antigua and Barbuda, Brunei Darussalam, Russian Federation, Bahamas, Panama, Oman, Georgia, Trinidad and Tobago, Barbados, Malaysia, Costa Rica, Serbia, Thailand, Kazakhstan, Seychelles, Belarus, Bulgaria, Palau, Mauritius, Grenada, Albania, China, Armenia, Mexico, Iran (Islamic Republic of), Sri Lanka, Bosnia and Herzegovina, Saint Vincent and the Grenadines, Dominican Republic, Ecuador, North Macedonia, Cuba, Moldova (Republic of), Maldives, Peru, Azerbaijan, Brazil, Colombia, Libya, Algeria, Turkmenistan, Guyana, Mongolia, Dominica, Tonga, Jordan, Ukraine, Tunisia, Marshall Islands, Paraguay, Fiji, Egypt, Uzbekistan, Viet Nam, Saint Lucia, Lebanon, South Africa, Palestine, Indonesia, Philippines, Botswana, Jamaica, Samoa, Kyrgyzstan, Belize, Venezuela, Bolivia, Morocco, Nauru, Gabon, Suriname, Bhutan, Tajikistan, El Salvador, Iraq, Bangladesh, Nicaragua, Cabo Verde, Tuvalu, Equatorial Guinea, India, Micronesia (Federated States of), Guatemala, Kiribati, Honduras, Lao People's Democratic Republic, Vanuatu, Sao Tome and Principe, Eswatini, Namibia, Myanmar, Ghana, Kenya, Nepal, Cambodia, Congo, Angola, Cameroon, Comoros, Zambia, Papua New Guinea, Timor-Leste, Solomon Islands, Syrian Arab Republic, Haiti, Uganda, Zimbabwe, Nigeria, Rwanda, Togo, Mauritania, Pakistan, Côte d'Ivoire, Tanzania (United Republic of), Lesotho, Senegal, Sudan, Djibouti, Malawi, Benin, Gambia, Eritrea, Ethiopia, Liberia, Madagascar, Guinea-Bissau, Democratic Republic of Congo, Guinea, Afghanistan, Mozambique, Sierra Leone, Burkina Faso, Yemen, Burundi, Mali, Chad, Niger, Central African Republic, South Sudan, Somalia, Democratic People's Rep. of Korea, Monaco, Norway, Iceland, Switzerland

1-(2-pyrimidinyl) piperazine / Controlled substance

  • Chemical formula: C8H12N4. Molecular weight: 164.21 g/mol. Also known as 1-pp its used in the psychological field to deal with anxiety. Currently available for legal medical uses in the USA and other geopolitical administrations

  • Corrosive, Irritant substance, Respiratory irritation, Damage/eye irritation, Organ toxicity

  • Select one to explore, then click icon

symptoms at least 

months at least 

bottom of page